- CEO
- Michael Hoffman
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 52 E. 83rd Street New York City NY United States of America 10028
- IPO Date
- Jun 16, 2025
- Business
- Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in 2022 and headquartered in New York, New York. The company is principally engaged in effecting mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more businesses. As a blank check company, Translational Development Acquisition Corp. does not have significant operations or products at present; rather, it focuses on identifying a private business suitable for public market access and growth through its expertise and capital. The company completed its initial public offering in December 2024, raising $172.5 million, and commenced separate trading of its Class A ordinary shares and warrants under the symbols TDAC and TDACW on Nasdaq in early 2025. Its management team, led by CEO Michael B. Hoffman, leverages extensive experience to source, evaluate, and structure prospective business combinations, targeting industries complementary to their background. The company operates primarily in the financial sector within the United States but intends to pursue acquisition opportunities across various industries and geographies, aiming to capitalize on strategic alliances and potential expansions post-business combination.